EN - General Report of Activities - Key achievements and governance: a year in review

Two briefing Throughout the year, the EMCDDA provided technical input notes were produced for the EU Presidency, the members of and advice to drug policymakers at the EU level, namely the the HDG and the European Commission on two topics, namely European Parliament, the Council of the European Union and an overview of the drug situation in the Western Balkans and the European Commission. [...] The EMCDDA Director had meetings with members of the In terms of further collaboration with the European European Parliament and presented the main findings of Commission, the Director had regular meetings throughout the the European Drug Report 2021 remotely to the Committee year with the Commission’s services (see ‘EMCDDA Director: for Civil Liberties, Justice and Home Affairs (LIBE). [...] The Director gave Coordinators, and the policy dialogues of the EU with China, presentations at the side event organised by the Russian USA, the Community of Latin American and Caribbean States Federation as well as at the EU side event organised by the (CELAC), Russia, the Western Balkans, the Dublin Group and Portuguese Presidency on the EU Drugs Strategy 2021-2025. [...] trends For example, in April the Austrian Federal Minister for the To support the comprehensive analytical effort in the security European Union and Constitution, Karoline Edtstadler, visited area, work continued in 2021 on improving the quality and the EMCDDA accompanied by a delegation of Austrian availability of core supply data, in close collaboration with the dignitaries, including the Austri. [...] The agency also contributed to challenges the planning and drafting of the respective OAPs for 2022, with several proposals that were accepted and supported by the In the policy area, the EMCDDA provided technical input drivers of the OAPs.